Fig. 6

OVOL1 is associated with multiple biological terms and signaling pathways in pancreatic cancer. (A) GO analysis of the DEGs (log2FC > 1, p adj < 0.05) in TCGA pancreatic cancer patients with OVOL1High versus OVOL1Low. (B) KEGG enrichment analysis of the DEGs (log2FC > 1, p adj < 0.05) in TCGA pancreatic cancer patients with OVOL1High versus OVOL1Low.